Weight-loss injections such as Ozempic have dominated headlines in recent years, with demand growing rapidly as treatments have become more widely discussed online. Now, experts are warning that hair-loss drugs could be heading in a similar direction, as rising public interest creates new opportunities for unregulated sellers.
New data obtained from the Medicines and Healthcare products Regulatory Agency (MHRA) has revealed that more than 65,000 doses of unlicensed hair-loss medicines have been seized since 2021.
The figures were obtained by Vip Italia, which supplies aesthetic equipment across Europe and worldwide, through a Freedom of Information request. The request asked for details of MHRA seizures involving medicines commonly used to manage hair loss, including eflornithine, finasteride and minoxidil.
In total, 65,194 individual doses were seized between 2021 and early 2026. The data shows a sharp increase in recent years, with 27,091 doses seized in 2025 alone, the highest number recorded during the period.
The full breakdown of the seizures is here:
- 2021 – 20,736
- 2022 – 0
- 2023 – 13,754
- 2024 – 3,413
- 2025 – 27,091
- 2026 – 200 so far
The findings come amid growing concern about the online sale of hair-loss treatments, particularly through websites and social media platforms where medicines can often be purchased quickly and cheaply.
In recent years, some hair-loss products have been promoted online as “miracle” treatments, promising fast results for people who may already feel vulnerable or distressed about their appearance. However, specialists warn that when medicines are bought from unverified sellers, people may be exposed to unsafe products, incorrect doses or drugs that are not what they claim to be.
Concerns have also been heightened by recent headlines involving a teacher who sadly ended his own life after taking a hair-loss drug he had purchased online. The case has drawn attention to the potential mental health risks associated with some treatments and the importance of proper medical supervision.
Search demand suggests that interest in these products is continuing to rise. In the past year alone, searches for minoxidil treatments increased by 32%, while interest in finasteride treatments rose by 7%.
In response to the findings, Anastasia Lesnikova, Chief Marketing Officer and Aesthetics Product Expert at VIP Italia, commented: “For many people, hair loss can be pretty distressing, affecting how you feel about yourself every day. When you are struggling with something like that, it is completely understandable to look for solutions wherever you can find them.
“But this increase in demand is creating an environment where illegal suppliers can thrive. While tens of thousands of illegal doses of hair-loss drugs are being intercepted before they reach the public, it is worrying to think that there may be many more circulating that have not yet been seized.
She said the market for hair-loss drugs could be approaching a turning point similar to the one seen with weight-loss injections.
“We could be looking at a ‘GLP-1 moment’ for hair-loss treatments. After all, as these medications become easier to access, we risk shifting from medically supervised treatments to mass-market ‘lifestyle drugs’. When treatments are reduced to a quick online questionnaire or a social media ad, it opens the door for sellers to target people’s insecurities. Many platforms do not even require an in-person consultation, overlooking important medical factors.
“At the end of the day, hair loss drugs are still medicines that affect the body. A proper consultation allows a doctor to check your medical history, discuss side effects and decide whether the treatment is appropriate. When that step is skipped, the potential risk increases.
The growth of online prescribing and direct-to-door delivery has made access to some medicines more convenient. However, experts say it has also made enforcement more difficult, especially when illegal sellers use social media advertising, overseas websites or misleading branding to reach consumers.
She added: “When products can be ordered with just a few clicks and delivered directly to someone’s home, enforcement becomes incredibly difficult. That’s why stronger oversight and clearer safeguards are needed.
“Although many hair-loss medications are legitimate treatments when prescribed and monitored properly, problems can arise when medicines are bought from unverified sellers or when products are taken without proper medical advice.
“Not to mention, some products may contain the wrong ingredients, while others may contain incorrect doses or contaminants. In some cases, people may not even be receiving the drug they think they are buying.”
Lesnikova said anyone concerned about the legitimacy of their medication should speak to a qualified professional.
“If you’re concerned about whether your hair loss drugs are legitimate, it’s always best to seek advice from a qualified medical professional and to use licensed pharmacies. It’s also a good idea to research medications before buying them and to be cautious of deals that seem too good to be true.
“As frustrating as hair loss can be, quick fixes can cause far more harm than good. Doing your research, speaking to a doctor and buying medicines from trusted sources can make all the difference when it comes to protecting your health.”
